A groundbreaking AI-powered device developed by Heartfelt Technologies in Cambridge could be set to revolutionise how heart failure is managed in the home, after receiving Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).

The funding will be used to expand go-to-market teams across the US and Europe

University of Cambridge researchers have discovered what appears to be a transformative method of identifying mutations linked to genetic disorders.

Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1.

Signaloid, a Cambridge computing platform company providing hardware and binary-translation-based acceleration of AI, robotics, aerospace, and quantitative finance workloads, has launched the tapeout and preliminary specifications documents for its C0-ASIC processor.

Renaissance has announced a strategic partnership with CyberSmart, a UK-based cybersecurity provider focused on delivering continuous protection, compliance, and cyber risk management for small and medium-sized enterprises (SMEs).

Signaloid previews a new ASIC purpose-built for physical AI and robotics workloads.

CPI Enterprises, part of the High Value Manufacturing Catapult, has invested £500,000 in Cambridge-based life sciences company Verinnogen to support the development of a novel technology designed to improve the accuracy and reliability of cancer drug development.

Kiril Kirov from Qureight discusses how synthetic control arms offer an alternative to conventional control groups and improve clinical trial design.

Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies.

The NHS is one of the world’s most ambitious public health systems, but it faces mounting pressures from an ageing population, chronic illnesses, and limited public funding.

Cutting-edge sound technology has laid bare a stark contrast in bird life between conventional and regenerative farming in just six days.